Literature DB >> 19450561

Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.

Soo-Kyung Shon1, Aeyung Kim, Ji Young Kim, Keun Il Kim, Young Yang, Jong-Seok Lim.   

Abstract

In the current study, we examined the function of N-myc downstream-regulated gene 2 (NDRG2) expression in breast cancer cells, especially focusing on the role of bone morphogenetic protein-4 (BMP-4) induced by NDRG2. NDRG2 expression in MDA-MB-231 cells inhibited the mRNA expression of several matrix metalloproteinases (MMPs) and the gelatinolytic activity of MMP-9. Interestingly, a specific induction of active BMP-4 was exclusively observed in MDA-MB-231-NDRG2 cells but not in MDA-MB-231-mock cells. Neutralization of BMP-4 in MDA-MB-231-NDRG2 cells resulted in the rescue of MMP-9 mRNA expression and migration capacity. In addition, treatment with recombinant BMP-4 dramatically suppressed MMP-9 mRNA expression, gelatinolytic MMP-9 activity, migration, and invasion capacity both in MDA-MB-231 and PMA-treated MCF-7 cells. Collectively, our data show that BMP-4 induced by NDRG2 expression inhibits the metastatic potential of breast cancer cells, especially via suppression of MMP-9 activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450561     DOI: 10.1016/j.bbrc.2009.05.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.

Authors:  Ji Ma; Wenchao Liu; Xiaohong Yan; Qianrong Wang; Qingli Zhao; Yan Xue; Hui Ren; Lin Wu; Yuanxiong Cheng; Sen Li; Lu Miao; Libo Yao; Jian Zhang
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

2.  Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9.

Authors:  Jing Xu; Danhong Zhu; Shozo Sonoda; Shikun He; Christine Spee; Stephen J Ryan; David R Hinton
Journal:  Angiogenesis       Date:  2012-03-04       Impact factor: 9.596

3.  BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells.

Authors:  Chuan Wang; Fen Hu; Shaocong Guo; Dong Mi; Wenwen Shen; Jie Zhang; Yuhuan Qiao; Tianhui Zhu; Shuang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-07       Impact factor: 4.553

4.  Expression of bone morphogenic protein-4 is inversely related to prevalence of lymph node metastasis in gastric adenocarcinoma.

Authors:  Seong-Gon Kim; Hye-Rim Park; Soo-Kee Min; Je-Yong Choi; Sung-Hoon Koh; Jong-Wan Kim; Hae-Wan Lee
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

5.  Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.

Authors:  Haofei Wang; Wujun Wang; Xuelian Wang; Kaican Cai; Hua Wu; Qun Ju; Zhiyong Huang; Xuhui Gao
Journal:  Med Oncol       Date:  2012-04-22       Impact factor: 3.064

Review 6.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

7.  Inhibition of BMP signaling reduces MMP-2 and MMP-9 expression and obstructs wound healing in regenerating fin of teleost fish Poecilia latipinna.

Authors:  Shailja Rajaram; Hiral Murawala; Pranav Buch; Sonam Patel; Suresh Balakrishnan
Journal:  Fish Physiol Biochem       Date:  2015-11-27       Impact factor: 2.794

8.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

9.  Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.

Authors:  Kevin Shee; Amanda Jiang; Frederick S Varn; Stephanie Liu; Nicole A Traphagen; Philip Owens; Cynthia X Ma; Jeremy Hoog; Chao Cheng; Todd R Golub; Ravid Straussman; Todd W Miller
Journal:  FASEB J       Date:  2018-08-30       Impact factor: 5.191

10.  Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.

Authors:  Jianhong Zuo; Meiling Wen; Sai Li; Xiu Lv; Lei Wang; Xiaohong Ai; Mingsheng Lei
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.